Cargando…

Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy

The 21-gene Recurrence Score (RS) assay is a validated prognosticator/predictor of chemotherapy (CT) benefit in early-stage estrogen receptor (ER)-positive breast cancer (BC). Long-term data from real-life clinical practice where treatment was guided by the RS result are lacking. We performed explor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stemmer, Salomon M., Steiner, Mariana, Rizel, Shulamith, Ben-Baruch, Noa, Uziely, Beatrice, Jakubowski, Debbie M., Baron, Julie, Shak, Steven, Soussan-Gutman, Lior, Bareket-Samish, Avital, Fried, Georgeta, Rosengarten, Ora, Itay, Amit, Nisenbaum, Bella, Katz, Daniela, Leviov, Michelle, Tokar, Margarita, Liebermann, Nicky, Geffen, David B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6841708/ https://www.ncbi.nlm.nih.gov/pubmed/31728408 http://dx.doi.org/10.1038/s41523-019-0137-3

Ejemplares similares

Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry
por: Stemmer, Salomon M., et al.
Publicado: (2017)

Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry
por: Stemmer, Salomon M., et al.
Publicado: (2017)

The impact of the 21-gene Recurrence Score assay on clinical decision-making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patients
por: Stemmer, Salomon M., et al.
Publicado: (2013)

Second breast cancer: recurrence score results, clinicopathologic characteristics, adjuvant treatments, and outcomes—exploratory analysis of the Clalit registry
por: Shachar, Shlomit S., et al.
Publicado: (2023)

Clinical outcomes in estrogen receptor-positive early-stage breast cancer patients with Recurrence Score 26-30: observational real-world cohort study
por: Rotem, Ofer, et al.
Publicado: (2023)

Factors Affecting Communication Patterns between Oncology Staff and Family Members of Deceased Patients: A Cross-Sectional Study
por: Granot, Tal, et al.
Publicado: (2016)

Targeting the A3 adenosine receptor to treat hepatocellular carcinoma: anti-cancer and hepatoprotective effects
por: Fishman, Pnina, et al.
Publicado: (2023)

Namodenoson Inhibits the Growth of Pancreatic Carcinoma via Deregulation of the Wnt/β-catenin, NF-κB, and RAS Signaling Pathways
por: Itzhak, Inbal, et al.
Publicado: (2023)

Hormone-Replacement Therapy and Its Association with Breast Cancer Subtypes: A Large Retrospective Cohort Study
por: Rosenberg, Vered, et al.
Publicado: (2021)

Three-month follow-up of durability of response to the third dose of the SARS-CoV-2 BNT162b2 vaccine in adults aged 60 years and older: a prospective cohort study
por: Eliakim-Raz, Noa, et al.
Publicado: (2022)

Bisphosphonates in the Adjuvant Setting of Breast Cancer Therapy—Effect on Survival: A Systematic Review and Meta-Analysis
por: Ben-Aharon, Irit, et al.
Publicado: (2013)

Doxorubicin-induced ovarian toxicity
por: Ben-Aharon, Irit, et al.
Publicado: (2010)

Phase II Study of Concurrent Capecitabine and External Beam Radiotherapy for Pain Control of Bone Metastases of Breast Cancer Origin
por: Kundel, Yulia, et al.
Publicado: (2013)

Premature ovarian aging in BRCA carriers: a prototype of systemic precocious aging?
por: Ben-Aharon, Irit, et al.
Publicado: (2018)

The Association between Treatment for Metabolic Disorders and Breast Cancer Characteristics
por: Goldvaser, Hadar, et al.
Publicado: (2016)

The association between smoking and breast cancer characteristics and outcome
por: Goldvaser, Hadar, et al.
Publicado: (2017)

Adjuvant Docetaxel and Cyclophosphamide (DC) with Prophylactic Granulocyte Colony-Stimulating Factor (G-CSF) on Days 8 &12 in Breast Cancer Patients: A Retrospective Analysis
por: Yerushalmi, Rinat, et al.
Publicado: (2014)

Metastatic Salivary Gland Tumors: A Single-Center Study Demonstrating the Feasibility and Potential Clinical Benefit of Molecular-Profiling-Guided Therapy
por: Popovtzer, Aron, et al.
Publicado: (2015)

Molecular Profiling-Selected Therapy for Treatment of Advanced Pancreaticobiliary Cancer: A Retrospective Multicenter Study
por: Epelbaum, Ron, et al.
Publicado: (2015)

Cervical Cancer Screening Among Patients with Physical Disability
por: Baruch, Lior, et al.
Publicado: (2022)

Hormone dependent metastatic salivary gland carcinoma: a case report
por: Agbarya, Abed, et al.
Publicado: (2014)

Randomised clinical trial: A phase 2 double‐blind study of namodenoson in non‐alcoholic fatty liver disease and steatohepatitis
por: Safadi, Rifaat, et al.
Publicado: (2021)

Treatment decisions in estrogen receptor-positive early breast cancer patients with intermediate oncotype DX recurrence score results
por: Fried, Georgeta, et al.
Publicado: (2014)

Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast cancer
por: Denys, Hannelore, et al.
Publicado: (2020)

Biopsy of breast cancer metastases: patient characteristics and survival
por: Shachar, Shlomit Strulov, et al.
Publicado: (2017)

Living with Parkinson’s disease: A qualitative study of spousal perspectives
por: Ressler, Itay, et al.
Publicado: (2022)

Psychological experiences of patients recovering from severe COVID-19 in rehabilitation: A qualitative study
por: Gershfeld-Litvin, Avital, et al.
Publicado: (2023)

Clinical and molecular characteristics of triple-negative breast cancer patients in Northern Israel: single center experience
por: Asleh-Aburaya, Karama, et al.
Publicado: (2015)

Durability of Response to SARS-CoV-2 BNT162b2 Vaccination in Patients on Active Anticancer Treatment
por: Eliakim-Raz, Noa, et al.
Publicado: (2021)

Development and Validation of a Tool Integrating the 21-Gene Recurrence Score and Clinical-Pathological Features to Individualize Prognosis and Prediction of Chemotherapy Benefit in Early Breast Cancer
por: Sparano, Joseph A., et al.
Publicado: (2021)

The chemistry of membranes used in fuel cells: degradation and stabilization
por: Schlick, Shulamith
Publicado: (2018)

Expressionism /
por: Behr, Shulamith
Publicado: (1999)

The Effect of Methodological Considerations on the Construction of Gene-Based Plant Pan-genomes
por: Glick, Lior, et al.
Publicado: (2023)

Fractured genes: a novel genomic arrangement involving new split inteins and a new homing endonuclease family
por: Dassa, Bareket, et al.
Publicado: (2009)

Constant-Beamwidth Beamforming with Concentric Ring Arrays
por: Kleiman, Avital, et al.
Publicado: (2021)

FGFR Fusions as an Acquired Resistance Mechanism Following Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) and a Suggested Novel Target in Advanced Non-Small Cell Lung Cancer (aNSCLC)
por: Raphael, Ari, et al.
Publicado: (2022)

Different solutions lead to similar life history traits across the great divides of the amniote tree of life
por: Meiri, Shai, et al.
Publicado: (2021)

Is Social Presence Indeed Present in Remote Social Interactions? A Call for Incorporating Physiological Measures of Synchrony When Assessing the Social Nature of Interpersonal Interactions via Videoconferencing Platforms
por: Gutman, Jenny, et al.
Publicado: (2022)

Country versus pharmaceutical company interests for hepatitis C treatment
por: Lothan, Roy, et al.
Publicado: (2022)

Cellulosomics of the cellulolytic thermophile Clostridium clariflavum
por: Artzi, Lior, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_b7bbvvoj1dehf170n65pftnn51